Drug intelligence / Profile preview

andrographis paniculata + withania somnifera

Development stage
Preclinical
Lead developer
Natural Remedies
Administration
Oral
01

Overview

This is a **combination of two herbal extracts:**\n- **Andrographis paniculata** ("king of bitters") is a plant used in traditional medicine, known for its anti-inflammatory, immunomodulatory, and antioxidant properties. Its primary bioactive compound is andrographolide, which has demonstrated anti-stress, anti-inflammatory, and immune regulatory effects in preclinical and limited clinical studies.\n- **Withania somnifera** ("ashwagandha") is an adaptogenic herb widely used in Ayurveda and traditional Indian medicine for stress reduction, enhancement of physical and mental performance, and immune modulation. Its main active constituents are withanolides.\nThe combination is used as an **adaptogenic** and **anti-stress** formulation, aiming to support resilience to stress, modulate immune and inflammatory responses, and mitigate some pathophysiological consequences of chronic stress. There is limited but emerging research, including at least one registered randomized placebo-controlled trial, on this specific combination in adaptogenic and anti-stress indications[5][1][7]. The principal mechanism for both ingredients involves the modulation of cytokine production and the hypothalamic-pituitary-adrenal (HPA) axis, with effects on cortisol/corticosterone and pro- and anti-inflammatory cytokines such as TNF-α, IL-1β, and IL-10[1].

Other names
andrographis + ashwagandhaandrographis and ashwagandhaashwagandha + andrographis

Beyond the preview

Go deeper on andrographis paniculata + withania somnifera.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on andrographis paniculata + withania somnifera.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call